CLCN1 and myopathy: Consistent with this is the observation that the muscle biopsy from patients and rats treated with fluvastatin exhibit manifestations of myopathy in which the skeletal muscles show lowered ClC-1 protein expression and decreased chloride conductance with no change in ClCN1 transcript levels [44,45,46].